Chong−Wen Bi

702 citations
35 papers · 588 indexed · h-index 13
Topics
Cancer therapeutics and mechanisms (7 papers)Metal complexes synthesis and properties (7 papers)Berberine and alkaloids research (6 papers)
Partner nations
ChinaUnited States

In The Last Decade

Chong−Wen Bi

34 papers receiving 576 citations

Peers

Chong−Wen Bi
Comparison fields: 5 of 82
  • Molecular Biology 316
  • Pharmacology 138
  • Organic Chemistry 115
  • Epidemiology 108
  • Oncology 81
Replace Sheng Tang with:
Sheng Tang China
Chiara Giommarelli Italy
Nana Du China
Malek Zihlif Jordan
Hamadeh Tarazi United Arab Emirates
Antonio Lupia Italy
Haihong Huang China
Serge H. Boyer United States
Julie Charton France
Chong−Wen Bi relative to Sheng Tang China Sheng Tang's profile →
Citations per field
00.5×1.5×
Sheng Tang · 1×
Citations per year

Countries citing papers authored by Chong−Wen Bi

Since Specialization
Citations

This map shows the geographic impact of Chong−Wen Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chong−Wen Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chong−Wen Bi more than expected).

Fields of papers citing papers by Chong−Wen Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chong−Wen Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chong−Wen Bi. The network helps show where Chong−Wen Bi may publish in the future.

Co-authorship network of co-authors of Chong−Wen Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Chong−Wen Bi. A scholar is included among the top collaborators of Chong−Wen Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chong−Wen Bi. Chong−Wen Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 9
2 0
3 1
4 6
5 10
6 1
7 5
8 44
9 19
10 12
11 8
12 9
13 27
14 22
15 9
16 22
17
[Synthesis and structure-activity relationship of N-(2-arylethyl) isoquinoline derivatives as anti-cancer agents].
1
18 54
19 36
20 27

About Chong−Wen Bi

Chong−Wen Bi is a scholar working on Pharmacology, Organic Chemistry and Oncology, having authored 35 papers that have together received 588 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (7 papers), Metal complexes synthesis and properties (7 papers) and Berberine and alkaloids research (6 papers). The work is most often cited by research in Pharmacology (138 citations), Toxicology (23 citations) and Pharmacology (51 citations). Chong−Wen Bi has collaborated with scholars based in China and United States. Frequent co-authors include Danqing Song, Yinghong Li, Sheng Tang, Yanxiang Wang, Rong‐Guang Shao, Wuli Zhao, Jian‐Dong Jiang, Yongqiang Shan, Nana Du and Limei Gao. Their work appears in journals such as Nature Communications, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026